现行二级预防体系依托高危型HPV（HR-HPV）检测与宫颈液基细胞学（LBC）检查双联筛查 ... 和高级别鳞状上皮内病变（HSIL）的检出率显著增加。

The company had posted a net profit of Rs 33.53 crore in January-March quarter a year ago, HSIL Ltd (CTIL) said in a BSE filing. Buy HSIL with 37% return potential, expect 15% CAGR over FY17-20 ...